Various types of extended spectrum β-lactamases: a literature review
Main Article Content
Keywords
antibiotic resistance, extended spectrum β-lactamases
Abstract
The inappropriate use of antibacterials causes the spread of resistance in bacteria and increases the health burden of infection due to the nature of resistance to many classes of antibiotics which are referred to as multi-resistant (multidrug resistant). Extended spectrum β-lactamase (ESBL) is one of the enzymes that cause multi-resistance, where bacteria with this enzyme become resistant to third-generation cephalosporin antibiotics which are often used to treat gram-positive and gram-negative bacterial infections in humans with minimal side effects. β -lactamase is an enzyme capable of hydrolyzing the β-lactam ring in β -lactam class antibiotics so that antibiotics become inactive. Mutations in the gene that encodes this enzyme produce a β-lactamase enzyme which can break down the β-lactam ring in all penicillin and cephalosporin antibiotics. The classification of β-lactamases is complex due to genetic, biochemical properties, and substrate affinity for β-lactamase inhibitors. There are also various types of ESBL enzyme-coding genes including TEM, SHV, CTX-M, VEB, PER, OXA, SFO-1, BEL-1, BES-1, TLA-1, and GES. This study aims to review various types of extended-spectrum β-lactamases.
References
2. Hayati Z, Jamil KF, Azhari A, Mahdani W, Karmil TF, Yossadania A, Dahril, Habibie YA. Outcome of urinary tract infection caused by Extended Spectrum Beta-Lactamase (ESBL) producing Escherichia coli and Klebsiella pneumoniae in Dr Zainoel Abidin General Hospital Aceh. Bali Medical Journal. 2021;10(2): 544-548.
3. Primeau CA, Bharat A, Janecko N, Carson CA, Mulvey M, Reid-Smith R, et al. Integrated surveillance of extended-spectrum beta-lactamase (ESBL) producing Salmonella and Escherichia coli from humans and animal species raised for human consumption in Canada from 2012 to 2017. Epidemiol Infect. 2022;151:e14.
4. Gómez-Sanz E, Bagutti C, Roth JA, Alt Hug M, García-Martín AB, Maurer Pekerman L, et al. Spatiotemporal dissemination of ESBL-producing Enterobacterales in municipal sewer systems: a prospective, longitudinal study in the city of Basel, Switzerland. Front Microbiol. 2023;14:1174336.
5. McDonald KL, Garland S, Carson CA, Gibbens K, Parmley EJ, Finley R, et al. Measures used to assess the burden of ESBL producing Escherichia coli infections in humans: a scoping review. JAC Antimicrob Resist. 2021;3(1):dlaa104.
6. Wedari NLPH, Sukrama IDM, Budayanti NNS, Sindhughosa DA, Prabawa IPY, Manuaba IBAP. One Health concept and role of animal reservoir in avian influenza: a literature review. Bali Medical Journal. 2021;10(2):515-520.
7. Ramatla T, Mafokwane T, Lekota K, Monyama M, Khasapane G, Serage N, et al. "One Health" perspective on prevalence of co-existing extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae: a comprehensive systematic review and meta-analysis. Ann Clin Microbiol Antimicrob. 2023;22(1):88.
8. Wedari NLPH, Budayanti NNS, Darwinata AE. Clostridium difficile virulence factors as the cause of antibiotic-associated diarrhea (AAD): a literature review. Bali Medical Journal. 2022;11(3):1277-1281.
9. van Hout D, Verschuuren TD, Bruijning-Verhagen PCJ, Bosch T, Schürch AC, Willems RJL, et al. Extended-spectrum beta-lactamase (ESBL)-producing and non-ESBL-producing Escherichia coli isolates causing bacteremia in the Netherlands (2014 - 2016) differ in clonal distribution, antimicrobial resistance gene and virulence gene content. PLoS One. 2020;15(1):e0227604.
10. Ae R, Sasahara T, Yoshimura A, Kosami K, Hatakeyama S, Sasaki K, et al. Prolonged carriage of ESBL-producing enterobacterales and potential cross-transmission among residents in geriatric long-term care facilities. Sci Rep. 2021;11(1):21607.
11. European Food Safety Authority (EFSA); European Centre for Disease Prevention and Control (ECDC). The European Union Summary Report on Antimicrobial Resistance in zoonotic and indicator bacteria from humans, animals and food in 2020/2021. EFSA J. 2023;21(3):e07867.
12. Andremont O, Armand-Lefevre L, Dupuis C, de Montmollin E, Ruckly S, et al. Semi-quantitative cultures of throat and rectal swabs are efficient tests to predict ESBL-Enterobacterales ventilator-associated pneumonia in mechanically ventilated ESBL carriers. Intensive Care Med. 2020;46(6):1232-1242.
13. Stone TJ, DeWitt M, Johnson JW, Beardsley JR, Munawar I, Palavecino E, et al. Analysis of infections among patients with historical culture positive for extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae: Is ESBL-targeted therapy always needed?. Antimicrob Steward Healthc Epidemiol. 2023;3(1):e47.
14. European Food Safety Authority; European Centre for Disease Prevention and Control. The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017. EFSA J. 2019;17(2):e05598.
15. Onduru OG, Mkakosya RS, Aboud S, Rumisha SF. Genetic Determinants of Resistance among ESBL-Producing Enterobacteriaceae in community and hospital settings in East, Central, and Southern Africa: a systematic review and meta-analysis of prevalence. Can J Infect Dis Med Microbiol. 2021;2021:5153237.